logo
Hybrid stationary phases: the answer to all of your matrix effect problems?
Matrix effects in quantitative bioanalytical validations: are reproducible results all that is necessary?
Predicting flu outbreaks: sensor technology holds promise
A modern approach to a medieval problem?
Companion diagnostics collaboration
Agilent Technologies to separate into two companies
Method developed for the detection of protein ions
Regulated bioanalysis of oligonucleotide therapeutics and biomarkers: qPCR versus chromatographic assays
Mobile phase pH and organic modifier in reversed-phase LC–ESI-MS bioanalytical methods: assessment of sensitivity, chromatography and correlation of retention time with in silico logD predictions
The development and validation of an UHPLC–MS/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma
The potential of electrophoretic sample pretreatment techniques and new instrumentation for bioanalysis, with a focus on peptidomics and metabolomics
The challenges of LC–MS/MS analysis of opiates and opioids in urine
Progress in the development of paper-based diagnostics for low-resource point-of-care settings
Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies
Acknowledgements